# FDA Inspection 1208871 - Bristol-Myers Squibb Company - June 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/ad863020-b34a-40d2-91ba-237fdca75cc3
Source feed: FDA_Inspections

> FDA Inspection 1208871 for Bristol-Myers Squibb Company on June 16, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208871
- Company Name: Bristol-Myers Squibb Company
- Inspection Date: 2023-06-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1327472 - 2026-06-23](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/de378b90-d0ad-4dc7-9e89-1ad871e6a8ef)
- [FDA Inspection 1275526 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/e6f01d89-0a13-4fb3-a74e-dfb41429a3bc)
- [FDA Inspection 1275526 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/388f57dd-7839-42b2-906e-2074e1ea5c67)
- [FDA Inspection 1236864 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/41559cd5-b35e-471a-8003-1db4082c038a)
- [FDA Inspection 1236864 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/0bfe5373-cbf9-4df1-b1ab-e2551263381b)

Company: https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d